Atlantic Edge Private Wealth Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Atlantic Edge Private Wealth Management's DFTX Position: Q3 2026 in Review
Atlantic Edge Private Wealth Management held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 193 shares worth $7.35K. The position accounts for ﹤0.01% of the portfolio, ranked #455.
Atlantic Edge Private Wealth Management first reported a position in DFTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $9.08K in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Atlantic Edge Private Wealth Management held 193 shares of Definium Therapeutics worth $7.35K as of Q3 2026.
- Atlantic Edge Private Wealth Management left its Definium Therapeutics share count unchanged in Q3 2026.
- Definium Therapeutics made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q3 2026, its #455 holding.
- Atlantic Edge Private Wealth Management first reported a position in Definium Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Atlantic Edge Private Wealth Management's Definium Therapeutics position peaked at $9.08K in Q2 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Atlantic Edge Private Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.